Arrowhead Pharmaceuticals 靶向补体因子siRNA疗法概念与临床进展-Targeting Complement Factor B with siRNA Concept to Clinic.pdfVIP

  • 2
  • 0
  • 约3.45万字
  • 约 19页
  • 2026-04-10 发布于广东
  • 举报

Arrowhead Pharmaceuticals 靶向补体因子siRNA疗法概念与临床进展-Targeting Complement Factor B with siRNA Concept to Clinic.pdf

TargetingComplementFactorBwith

siRNA:ConcepttoClinic

ComplementBasedDrugDevelopmentSummit

Boston,MA

December11,2024

Conflicts

•Arrowheademployeeandshareholder

ComplementBasedDrugDevelopmentSummit

文档评论(0)

1亿VIP精品文档

相关文档